Policy | March 16, 2023
2654 compounds screened for different activities for GPCR profiling: Dr Jitendra Singh
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
J. B. Chemicals & Pharmaceuticals has informed that the acquisition of the Razel franchise from Glenmark Pharmaceuticals Limited has been successfully completed.
Results showed a statistically significant and clinically meaningful improvement in investigator-assessed progression-free survival
This is the first injectable product approval from our General Sterile Facility (F-3) which was inspected in August, 2022.
The FDA informed Astellas that it did not have sufficient information to assess the risks to subjects
It´s the first trial to demonstrate the benefits of dual pathway inhibition
First and only FDA-approved device of its kind demonstrates consistently high rates of target limb salvage and freedom from clinically-driven target lesion revascularization
New kit enhances menu of FFPE solutions and allows oncology researchers to extract higher yields of concentrated DNA compared to traditional techniques
In May 2021, Daiichi Sankyo had submitted a supplemental new drug application (sNDA) for Tarlige tablets based on results from a phase 3 trial in patients with CNP
The centre will initially employ 170 engineers, bringing the total number of Boston Scientific’s R&D employees in India to more than 300
Subscribe To Our Newsletter & Stay Updated
